tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Lawson, 14 are a SELL (6.6%), 171 are a BUY (80.66%), 27 are a HOLD (12.74%).
Analyst Peter Lawson, currently employed at BARCLAYS, carries an average stock price target met ratio of 61.54% that have a potential upside of 40.98% achieved within 303 days.
Peter Lawson’s has documented 440 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNDX, Syndax Pharmaceuticals at 04-Nov-2025.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 9/8/2015. The price target of $103 was fulfilled within 2 days with a profit of $18.62 (22.07%) receiving and performance score of 110.33.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 26-Dec-2025
$40
$12.82 (47.17%)
$34
13 days ago
(26-Dec-2025)
12/16 (75%)
$15.41 (62.67%)
187
Buy
Since 16-Feb-2024
$38
$10.82 (39.81%)
$32
13 days ago
(26-Dec-2025)
7/10 (70%)
$13.41 (54.53%)
62
Buy
Since 03-Dec-2021
$34
$6.82 (25.09%)
$32
13 days ago
(26-Dec-2025)
7/13 (53.85%)
$9.41 (38.27%)
409
Buy
Since 10-Oct-2024
$51
1 months 15 days ago
(24-Nov-2025)
1/1 (100%)
$9.18 (21.95%)
27
Buy
Since 24-Feb-2025
$48
$20.82 (76.60%)
$56
1 months 18 days ago
(21-Nov-2025)
0/4 (0%)
$2.51 (5.52%)
Which stock is Peter Lawson is most bullish on?
Which stock is Peter Lawson is most reserved on?
What Year was the first public recommendation made by Peter Lawson?
